Successful giant spine tumour surgery performed on a 12-year-old boy from Bangladesh
-Tumour measuring 15x15x20 cms in dimension was removed in a single-stage surgery-
Chennai, February 20th, 2020: A 12-year-old boy from Bangladesh diagnosed with giant nerve sheath tumour measuring 15X15X20 cms covering the entire lower part of the neck, was removed successfully in a 12-hour marathon single-stage surgery by a team of experts at Gleneagles Global Health City, Chennai. The boy’s condition was very critical as the tumour was extending into the left side of the neck and chest cavity.
The boy visited the neurosurgery department with complaints of swelling on the left side of his neck above the collar bone which was growing backward towards the cervical spine; he was in pain from the past two years. The tumour had completely destroyed the bones in the lower neck and the major blood vessels on the left side of the neck were encased and displaced by this large tumour. His reports confirmed a giant nerve sheath tumour.
A multi-disciplinary team of doctors led by Dr Nigel Symss (Senior Consultant Neurosurgeon) along with Dr PhaniKiran S (Senior Consultant Spine Surgeon), Dr Rajkumar (Senior Consultant Vascular Surgeon), Dr Jagannath PM (Neurosurgeons), Dr Arul K (Neurosurgeons) and Dr Ramana (Neuro-Anaesthetist & Neuro-critical care) after complete examination and investigations of the boy, decided to remove this large tumour in a single stage surgery.
Talking about the case, Dr Nigel Symss, Senior Consultant Neurosurgeon, Gleneagles Global Health City, said, “The advantage of single-stage surgery is less amount of blood loss, less chances of infection, avoiding a second surgery and a shorter hospital stay. These kinds of the tumours are a benign schwannoma and are slow-growing; if not diagnosed early may cause serious neurological deficits and instability of the spine. Giant dumbbell spinal schwannomas are uncommon lesions and their surgical treatment is demanding and challenging, requiring a multidisciplinary team approach for achieving good functional recovery.”
The microsurgical excision of the tumour was performed using a microscope and CUSA. The nerves and major neck vessels around this tumour were delicately separated by the expert surgeons in a 12-hour long single-stage surgery.
Dr Rajkumar, Senior Consultant, Vascular Surgeon, Gleneagles Global Health City, said, “The surgery was so challenging that any damage to the blood vessels or nerves during the surgery would have led to a major stroke or paralysis to the boy.”
“The accepted treatment for these benign tumours is complete surgical resection where feasible, and where indicated, vertebral fixation”, added Dr Phani Kiran, Senior Consultant, Spine Surgeon, Gleneagles Global Health City.
The tumour was removed completely and the destroyed part of cervical spine was stabilized with titanium cage and plate with screws. He is recovering well and undergoing physiotherapy and he has no new neurological deficits.
About Gleneagles Global Health City, Chennai
Gleneagles Global Health City, the sprawling 21-acre facility located in Perumbakkam, Chennai is the largest facility of Gleneagles Global Hospitals India. With a capacity of over 1000 beds and accreditations from leading agencies, the facility is Asia’s most trusted and leading Multi-Organ Transplant Centre. The hospital has undertaken several path-breaking Liver, Neuro, Heart, Lung and Kidney procedures. It is recognized by several international and national level accrediting agencies. World-class infrastructure, dedicated staff and a commitment for medical excellence are the USPs of this facility. The hospital has several achievements to its credit and continues to work on several pioneering procedures.
Gleneagles Global Hospitals has multi-super speciality hospitals in Bengaluru, Hyderabad, Chennai and Mumbai. The brand is the most preferred hospital group for multi-organ transplants in Asia region. The parent entity of Gleneagles Global Hospitals is IHH Healthcare, a leading premium integrated healthcare provider with a network of 84 hospitals and more than 16,000 licensed beds. It is one of the largest healthcare groups in the world by market capitalisation and is listed in the Main Market of Bursa Malaysia and Main Board of SGX-ST. IHH is a leading player in the home markets of Malaysia, Singapore, Turkey and India, and in their key growth markets of China and Hong Kong.